April 26, 2018
Susan G. Komen® Recognizes Renowned Investigators as 2017 Recipients of Brinker Awards for Scientific Distinction
October 5, 2017
September 9, 2017
June 29, 2017
A molecular test can pinpoint which patients will have a very low risk of death from breast cancer even 20 years after diagnosis and tumor removal, according to a new clinical study led by UC San Francisco in collaboration with colleagues in Sweden. As a result, “ultralow” risk patients could be treated less aggressively and overtreatment avoided, leading to fewer toxic effects.
June 15, 2017
Asian-American women are more likely to experience delays in follow-up treatment after an abnormal mammogram compared to white women, according to new UC San Francisco research.
May 9, 2017